TY - JOUR
T1 - Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol
T2 - A Multicenter Exploratory Longitudinal Study
AU - Al Tunaiji, Hashel
AU - Al Qubaisi, Mai
AU - Dalkilinc, Murat
AU - Campos, Luciana Aparecida
AU - Ugwuoke, Nnamdi Valbosco
AU - Alefishat, Eman
AU - Aloum, Lujain
AU - Ross, Ramzy
AU - Almahmeed, Wael
AU - Baltatu, Ovidiu-Constantin
N1 - Funding Information:
The authors gratefully acknowledge Hariklia Kia Kornas, Manager Research Compliance and Training for her support and help for the development of an Effective Project Risk Management Process. We thank the reviewers for their constructive comments, which helped us to improve the manuscript. Funding. This research is supported by Khalifa University of Science and Technology under Award No. CPRA-2020-034 to OB.
Funding Information:
This research is supported by Khalifa University of Science and Technology under Award No. CPRA-2020-034 to OB.
Publisher Copyright:
© Copyright © 2020 Al Tunaiji, Al Qubaisi, Dalkilinc, Campos, Ugwuoke, Alefishat, Aloum, Ross, Almahmeed and Baltatu.
PY - 2020/12/22
Y1 - 2020/12/22
N2 - Introduction: The coronavirus disease 2019 (COVID-19) pandemic has created new and unpredictable challenges for healthcare systems. Healthcare professionals are heavily affected by this rapidly changing situation, especially frontline healthcare professionals who are directly engaged in the diagnosis, treatment, and care of patients with COVID-19 and may experience psychological burdens. The objective of this study is to explore the evolution of psychosocial, cardiovascular, and immune markers in healthcare professionals with different levels of exposure to the COVID-19 pandemic. Methods and Analysis: This is a STROBE compliant, blended, exploratory study involving online and onsite approaches that use wearable monitoring. A planned random probability sample of residents, staff physicians, nurses, and auxiliary healthcare professionals will be recruited. The study sample will be stratified by exposure to the COVID-19 pandemic. As a first step, recruitment will be conducted online, with e-consent and using e-surveys with Maslach Burnout Inventory, Fuster-BEWAT score, and sociodemographic characteristics. Onsite visits will be planned for the second step where participants will receive a wearable setup that will measure heart rate, actimetry, and sleep quality monitoring, which will be used together with blood sampling for immune biomarkers. Steps 1 and 2 will then be repeated at 2–3 months, and 6 months. Power BI and Tableau will be used for data visualization, while front-end data capture will be used for data collection using specific survey/questionnaires, which will enable data linkage between e-surveys, internet of things wearable devices, and clinical laboratory data. Clinical Trial Registration: ClinicalTrials.gov;
AB - Introduction: The coronavirus disease 2019 (COVID-19) pandemic has created new and unpredictable challenges for healthcare systems. Healthcare professionals are heavily affected by this rapidly changing situation, especially frontline healthcare professionals who are directly engaged in the diagnosis, treatment, and care of patients with COVID-19 and may experience psychological burdens. The objective of this study is to explore the evolution of psychosocial, cardiovascular, and immune markers in healthcare professionals with different levels of exposure to the COVID-19 pandemic. Methods and Analysis: This is a STROBE compliant, blended, exploratory study involving online and onsite approaches that use wearable monitoring. A planned random probability sample of residents, staff physicians, nurses, and auxiliary healthcare professionals will be recruited. The study sample will be stratified by exposure to the COVID-19 pandemic. As a first step, recruitment will be conducted online, with e-consent and using e-surveys with Maslach Burnout Inventory, Fuster-BEWAT score, and sociodemographic characteristics. Onsite visits will be planned for the second step where participants will receive a wearable setup that will measure heart rate, actimetry, and sleep quality monitoring, which will be used together with blood sampling for immune biomarkers. Steps 1 and 2 will then be repeated at 2–3 months, and 6 months. Power BI and Tableau will be used for data visualization, while front-end data capture will be used for data collection using specific survey/questionnaires, which will enable data linkage between e-surveys, internet of things wearable devices, and clinical laboratory data. Clinical Trial Registration: ClinicalTrials.gov;
KW - burnout—professional
KW - cardiovascular risk (CV risk)
KW - COVID-19
KW - healthcare professional
KW - immune dysfunction
UR - http://www.scopus.com/inward/record.url?scp=85098955952&partnerID=8YFLogxK
U2 - 10.3389/fmed.2020.571057
DO - 10.3389/fmed.2020.571057
M3 - Article
AN - SCOPUS:85098955952
SN - 2296-858X
VL - 7
JO - Frontiers in Medicine
JF - Frontiers in Medicine
M1 - 571057
ER -